Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling)
暂无分享,去创建一个
[1] Maxime Pinard,et al. MUC16 (CA125) regulates epithelial ovarian cancer cell growth, tumorigenesis and metastasis. , 2011, Gynecologic oncology.
[2] L. Borsig,et al. Altered Tumor-Cell Glycosylation Promotes Metastasis , 2014, Front. Oncol..
[3] R. Hughey,et al. MUC1 Membrane Trafficking Is Modulated by Multiple Interactions* , 2004, Journal of Biological Chemistry.
[4] J. Rhodes,et al. Interaction between circulating galectin-3 and cancer-associated MUC1 enhances tumour cell homotypic aggregation and prevents anoikis , 2010, Molecular Cancer.
[5] M. Hollingsworth,et al. Cancer biomarkers defined by autoantibody signatures to aberrant O-glycopeptide epitopes. , 2010, Cancer research.
[6] Laura A. Sullivan,et al. Global Survey of Phosphotyrosine Signaling Identifies Oncogenic Kinases in Lung Cancer , 2007, Cell.
[7] R. Cummings,et al. Cloning and Expression of Human Core 1 β1,3-Galactosyltransferase* , 2002, The Journal of Biological Chemistry.
[8] K. Carraway,et al. O‐glycosylation pathway for mucin‐type glycoproteins , 1989, BioEssays : news and reviews in molecular, cellular and developmental biology.
[9] S. Cascio,et al. Altered glycosylation of MUC1 influences its association with CIN85: the role of this novel complex in cancer cell invasion and migration , 2013, Oncotarget.
[10] M. Hollingsworth,et al. MUC1 regulates cyclin D1 gene expression through p120 catenin and β-catenin , 2014, Oncogenesis.
[11] Xiaofeng Yu,et al. Aberrant Cosmc genes result in Tn antigen expression in human colorectal carcinoma cell line HT-29. , 2015, International journal of clinical and experimental pathology.
[12] M. Hollingsworth,et al. Overexpression of MUC1 reconfigures the binding properties of tumor cells , 2001, International journal of cancer.
[13] D. Kufe,et al. Protein Kinase C δ Regulates Function of the DF3/MUC1 Carcinoma Antigen in β-Catenin Signaling* , 2002, The Journal of Biological Chemistry.
[14] Jian Yu,et al. Survey of Tyrosine Kinase Signaling Reveals ROS Kinase Fusions in Human Cholangiocarcinoma , 2011, PloS one.
[15] I. Gipson,et al. Epithelial mucins of the ocular surface: structure, biosynthesis and function. , 2001, Experimental eye research.
[16] Kunling Xie,et al. The role of the AMOP domain in MUC4/Y-promoted tumour angiogenesis and metastasis in pancreatic cancer , 2016, Journal of Experimental & Clinical Cancer Research.
[17] Sandra J. Gendler. MUC1, The Renaissance Molecule , 2001, Journal of Mammary Gland Biology and Neoplasia.
[18] Lynette M. Smith,et al. Mucins and associated glycan signatures in colon adenoma-carcinoma sequence: Prospective pathological implication(s) for early diagnosis of colon cancer. , 2016, Cancer letters.
[19] Judy M. Anderson,et al. Pathobiological Implications of MUC16 Expression in Pancreatic Cancer , 2011, PloS one.
[20] T. Owczarek,et al. MUC1 in human and murine mammary carcinoma cells decreases the expression of core 2 β1,6-N-acetylglucosaminyltransferase and β-galactoside α2,3-sialyltransferase. , 2012, Glycobiology.
[21] E. Bennett,et al. A family of UDP-GalNAc: polypeptide N-acetylgalactosaminyl-transferases control the initiation of mucin-type O-linked glycosylation. , 1996, Glycobiology.
[22] D. Kufe,et al. Distinct evolution of the human carcinoma-associated transmembrane mucins, MUC1, MUC4 AND MUC16. , 2006, Gene.
[23] Nicolle H. Packer,et al. Mucin‐type O‐glycosylation – putting the pieces together , 2010, The FEBS journal.
[24] Lynette M. Smith,et al. Aberrant expression of MUC4 in ovarian carcinoma: diagnostic significance alone and in combination with MUC1 and MUC16 (CA125) , 2006, Modern Pathology.
[25] Xiaolong Wei,et al. Human MUC1 oncoprotein regulates p53-responsive gene transcription in the genotoxic stress response. , 2005, Cancer cell.
[26] B. Xia,et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc (Cancer Research (2008) 68, (1636-1646)) , 2008 .
[27] M. Stack,et al. Membrane-type I matrix metalloproteinase-dependent ectodomain shedding of mucin16/ CA-125 on ovarian cancer cells modulates adhesion and invasion of peritoneal mesothelium , 2014, Biological chemistry.
[28] J. Ladbury,et al. Identification of a Novel Proline-Arginine Motif Involved in CIN85-dependent Clustering of Cbl and Down-regulation of Epidermal Growth Factor Receptors* , 2003, Journal of Biological Chemistry.
[29] N. Schultz,et al. Expression of the Carboxy-Terminal Portion of MUC16/CA125 Induces Transformation and Tumor Invasion , 2015, PloS one.
[30] T. Okada,et al. Core 3 synthase is down-regulated in colon carcinoma and profoundly suppresses the metastatic potential of carcinoma cells. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[31] J. Peter-Katalinic,et al. High Density O-Glycosylation on Tandem Repeat Peptide from Secretory MUC1 of T47D Breast Cancer Cells* , 1999, The Journal of Biological Chemistry.
[32] F. Hanisch,et al. O-Glycosylation of the Mucin Type , 2001, Biological chemistry.
[33] O. Weisz,et al. Recycling of MUC1 Is Dependent on Its Palmitoylation* , 2006, Journal of Biological Chemistry.
[34] I. Brockhausen,et al. Mechanisms underlying aberrant glycosylation of MUC1 mucin in breast cancer cells. , 1995, European journal of biochemistry.
[35] S. Batra,et al. Mucins in the pathogenesis of breast cancer: implications in diagnosis, prognosis and therapy. , 2011, Biochimica et biophysica acta.
[36] J. Olsen,et al. Immature truncated O-glycophenotype of cancer directly induces oncogenic features , 2014, Proceedings of the National Academy of Sciences.
[37] Y. Kooyk,et al. Regulation of effector T cells by antigen-presenting cells via interaction of the C-type lectin MGL with CD45 , 2006, Nature Immunology.
[38] S. Hsu,et al. C2GnT-M is downregulated in colorectal cancer and its re-expression causes growth inhibition of colon cancer cells , 2006, Oncogene.
[39] J. Gonzalez-Bosquet,et al. MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress , 2014, Molecular Cancer.
[40] I. van Seuningen,et al. The MUC1 oncomucin regulates pancreatic cancer cell biological properties and chemoresistance. Implication of p42-44 MAPK, Akt, Bcl-2 and MMP13 pathways. , 2015, Biochemical and biophysical research communications.
[41] M. Hollingsworth,et al. Control of O-Glycan Branch Formation , 1999, The Journal of Biological Chemistry.
[42] S. Batra,et al. Structure, evolution, and biology of the MUC4 mucin , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[43] Subodh M. Lele,et al. MUC4 Overexpression Augments Cell Migration and Metastasis through EGFR Family Proteins in Triple Negative Breast Cancer Cells , 2013, PloS one.
[44] J. Meza,et al. MUC4 mucin interacts with and stabilizes the HER2 oncoprotein in human pancreatic cancer cells. , 2008, Cancer research.
[45] M. Oka,et al. Increased expression of MUC1 in advanced pancreatic cancer , 2003, Journal of Gastroenterology.
[46] S. Batra,et al. Genomic organization of MUC4 mucin gene. Towards the characterization of splice variants. , 2002, European journal of biochemistry.
[47] S. Batra,et al. MUC16: molecular analysis and its functional implications in benign and malignant conditions , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[48] D. Kufe,et al. Interaction of Glycogen Synthase Kinase 3β with the DF3/MUC1 Carcinoma-Associated Antigen and β-Catenin , 1998, Molecular and Cellular Biology.
[49] S. Batra,et al. Novel HER3/MUC4 oncogenic signaling aggravates the tumorigenic phenotypes of pancreatic cancer cells , 2015, Oncotarget.
[50] S. Batra,et al. Regulation of mucin expression: mechanistic aspects and implications for cancer and inflammatory diseases. , 2006, Biochimica et biophysica acta.
[51] P. Singh,et al. The reactive tumor microenvironment: MUC1 signaling directly reprograms transcription of CTGF , 2010, Oncogene.
[52] S. Gendler,et al. Structure and function of the cell surface (tethered) mucins. , 2008, Annual review of physiology.
[53] Denny G. A. Johansson,et al. Autoproteolysis coupled to protein folding in the SEA domain of the membrane-bound MUC1 mucin , 2006, Nature Structural &Molecular Biology.
[54] A. Gammerman,et al. Autoantibodies to MUC1 glycopeptides cannot be used as a screening assay for early detection of breast, ovarian, lung or pancreatic cancer , 2013, British Journal of Cancer.
[55] C. Lombardo,et al. Structure, Function and Gene Expression of Epithelial Mucins , 1997, Tumori.
[56] C. Rancourt,et al. MUC16 provides immune protection by inhibiting synapse formation between NK and ovarian tumor cells , 2010, Molecular Cancer.
[57] D. Kufe. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches , 2013, Oncogene.
[58] K. Shigemasa,et al. The CA 125 Gene: A Newly Discovered Extension of the Glycosylated N-Terminal Domain Doubles the Size of This Extracellular Superstructure , 2002, Tumor Biology.
[59] J. Hirabayashi,et al. Galectin-3 Interaction with Thomsen-Friedenreich Disaccharide on Cancer-associated MUC1 Causes Increased Cancer Cell Endothelial Adhesion* , 2007, Journal of Biological Chemistry.
[60] J. Sheehan,et al. Mucous glycoproteins: a gel of a problem. , 1985, Essays in biochemistry.
[61] Michael A. Hollingsworth,et al. Mucins in cancer: protection and control of the cell surface , 2004, Nature Reviews Cancer.
[62] B. Yin,et al. Molecular Cloning of the CA125 Ovarian Cancer Antigen , 2001, The Journal of Biological Chemistry.
[63] A. Moore,et al. Expression of underglycosylated MUC1 antigen in cancerous and adjacent normal breast tissues. , 2013, Clinical breast cancer.
[64] D. Kufe. Functional targeting of the MUC1 oncogene in human cancers , 2009, Cancer biology & therapy.
[65] F. Bard,et al. Regulation of O-glycosylation through Golgi-to-ER relocation of initiation enzymes , 2010, The Journal of cell biology.
[66] R. Cummings,et al. A unique molecular chaperone Cosmc required for activity of the mammalian core 1 β3-galactosyltransferase , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[67] C. Rancourt,et al. MUC16 mucin (CA125) regulates the formation of multicellular aggregates by altering β-catenin signaling. , 2015, American journal of cancer research.
[68] M. Hollingsworth,et al. The role of the SEA (sea urchin sperm protein, enterokinase and agrin) module in cleavage of membrane‐tethered mucins , 2005, The FEBS journal.
[69] R. Cummings,et al. Regulation of protein O-glycosylation by the endoplasmic reticulum–localized molecular chaperone Cosmc , 2008, The Journal of cell biology.
[70] D. Kufe,et al. The Human DF3/MUC1 carcinoma-associated antigen signals nuclear localization of the catenin p120(ctn). , 2001, Biochemical and biophysical research communications.
[71] K. Pienta,et al. Alpha 1,3 fucosyltransferases are master regulators of prostate cancer cell trafficking , 2009, Proceedings of the National Academy of Sciences.
[72] Lawrence A Tabak,et al. Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. , 2012, Glycobiology.
[73] H. Nakada,et al. CA125/MUC16 interacts with Src family kinases, and over-expression of its C-terminal fragment in human epithelial cancer cells reduces cell-cell adhesion. , 2013, European journal of cell biology.
[74] H. Inoue,et al. Expression of α-1,3-Fucosyltransferase Type IV and VII Genes Is Related to Poor Prognosis in Lung Cancer , 1996 .
[75] Henrik Clausen,et al. Mucin-type O-glycosylation and its potential use in drug and vaccine development. , 2008, Biochimica et biophysica acta.
[76] C. Rancourt,et al. Downregulation of cell surface CA125/MUC16 induces epithelial-to-mesenchymal transition and restores EGFR signalling in NIH:OVCAR3 ovarian carcinoma cells , 2011, British Journal of Cancer.
[77] T. Terada. An immunohistochemical study of primary signet-ring cell carcinoma of the stomach and colorectum: II. Expression of MUC1, MUC2, MUC5AC, and MUC6 in normal mucosa and in 42 cases. , 2013, International journal of clinical and experimental pathology.
[78] G. Springer. T and Tn, general carcinoma autoantigens. , 1984, Science.
[79] Chiun-Sheng Huang,et al. Up-regulation of C1GALT1 promotes breast cancer cell growth through MUC1-C signaling pathway , 2015, Oncotarget.
[80] D. Kufe,et al. Association of the DF3/MUC1 breast cancer antigen with Grb2 and the Sos/Ras exchange protein. , 1995, Cancer research.
[81] S. Hakomori,et al. Aberrant glycosylation in cancer cell membranes as focused on glycolipids: overview and perspectives. , 1985, Cancer research.
[82] R. Cummings,et al. The Transmembrane Domain of the Molecular Chaperone Cosmc Directs Its Localization to the Endoplasmic Reticulum* , 2011, The Journal of Biological Chemistry.
[83] M. Hollingsworth,et al. Identification of FRA-1 as a novel player in pancreatic cancer in cooperation with a MUC1: ERK signaling axis , 2016, Oncotarget.
[84] I. Gipson,et al. Suppression of Toll-like Receptor-Mediated Innate Immune Responses at the Ocular Surface by the Membrane-associated Mucins MUC1 and MUC16 , 2014, Mucosal Immunology.
[85] H. Kai,et al. Phosphoinositide 3-kinase is activated by MUC1 but not responsible for MUC1-induced suppression of Toll-like receptor 5 signaling. , 2007, American journal of physiology. Lung cellular and molecular physiology.
[86] Kwok-Kin Wong,et al. Targeting the Oncogenic MUC1-C Protein Inhibits Mutant EGFR-Mediated Signaling and Survival in Non–Small Cell Lung Cancer Cells , 2014, Clinical Cancer Research.
[87] S. Batra,et al. Current status of mucins in the diagnosis and therapy of cancer , 2009, BioFactors.
[88] P. Singh,et al. Cell surface-associated mucins in signal transduction. , 2006, Trends in cell biology.
[89] B. Yin,et al. Ovarian cancer antigen CA125 is encoded by the MUC16 mucin gene , 2002, International journal of cancer.
[90] Michael Hust,et al. Expression of Recombinant Antibodies , 2013, Front. Immunol..
[91] Y. Takeshima,et al. Expression of MUC1, MUC2, MUC5AC, and MUC6 in atypical adenomatous hyperplasia, bronchioloalveolar carcinoma, adenocarcinoma with mixed subtypes, and mucinous bronchioloalveolar carcinoma of the lung. , 2004, American journal of clinical pathology.
[92] T. O'brien,et al. The CA 125 Gene: An Extracellular Superstructure Dominated by Repeat Sequences , 2001, Tumor Biology.
[93] K. Carraway,et al. The membrane mucin Muc4 inhibits apoptosis induced by multiple insults via ErbB2-dependent and ErbB2-independent mechanisms. , 2009, Cancer research.
[94] J. Epstein,et al. MUC2 expression in primary mucinous and nonmucinous adenocarcinoma of the prostate: an analysis of 50 cases on radical prostatectomy , 2008, Modern Pathology.
[95] S. Batra,et al. MUC16 induced rapid G2/M transition via interactions with JAK2 for increased proliferation and anti-apoptosis in breast cancer cells , 2012, Oncogene.
[96] I. Ellis,et al. Expression of mucins (MUC1, MUC2, MUC3, MUC4, MUC5AC and MUC6) and their prognostic significance in human breast cancer , 2005, Modern Pathology.
[97] Christoph Wagener,et al. COSMC knockdown mediated aberrant O-glycosylation promotes oncogenic properties in pancreatic cancer , 2015, Molecular Cancer.
[98] M. King,et al. Three to Tango: MUC1 as a Ligand for Both E-Selectin and ICAM-1 in the Breast Cancer Metastatic Cascade , 2012, Front. Oncol..
[99] E. Cooper,et al. An evaluation of DUPAN-2 in pancreatic cancer and gastrointestinal disease. , 1990, British Journal of Cancer.
[100] G. Meijer,et al. The C-type lectin MGL expressed by dendritic cells detects glycan changes on MUC1 in colon carcinoma , 2007, Cancer Immunology, Immunotherapy.
[101] C. A. Carraway,et al. Muc4/sialomucin complex, the intramembrane ErbB2 ligand, induces specific phosphorylation of ErbB2 and enhances expression of p27kip, but does not activate mitogen-activated kinase or protein kinaseB/Akt pathways , 2002, Oncogene.
[102] S. Batra,et al. Membrane proximal ectodomain cleavage of MUC16 occurs in the acidifying Golgi/post-Golgi compartments , 2015, Scientific Reports.
[103] G. Apodaca,et al. Clathrin-mediated endocytosis of MUC1 is modulated by its glycosylation state. , 2000, Molecular biology of the cell.
[104] Hongyan Yuan,et al. Mucin1 shifts Smad3 signaling from the tumor-suppressive pSmad3C/p21WAF1 pathway to the oncogenic pSmad3L/c-Myc pathway by activating JNK in human hepatocellular carcinoma cells , 2015, Oncotarget.
[105] J. Isola,et al. Decreased accessibility and lack of activation of ErbB2 in JIMT-1, a herceptin-resistant, MUC4-expressing breast cancer cell line. , 2005, Cancer research.
[106] R. Gupta,et al. Subunit structure of porcine submaxillary mucin. , 1989, Biochemistry.
[107] P. Cheng,et al. Mucin O-glycan branching enzymes: structure, function, and gene regulation. , 2011, Advances in experimental medicine and biology.
[108] Henrik Clausen,et al. Location, location, location: new insights into O-GalNAc protein glycosylation. , 2011, Trends in cell biology.
[109] Alexandria P. Cogdill,et al. Engineered CAR T Cells Targeting the Cancer-Associated Tn-Glycoform of the Membrane Mucin MUC1 Control Adenocarcinoma. , 2016, Immunity.
[110] P. Schlag,et al. Overexpression of sialyltransferase CMP-sialic acid:Galbeta1,3GalNAc-R alpha6-Sialyltransferase is related to poor patient survival in human colorectal carcinomas. , 2001, Cancer research.
[111] G. Springer. Tn epitope (N-acetyl-D-galactosamine alpha-O-serine/threonine) density in primary breast carcinoma: a functional predictor of aggressiveness. , 1989, Molecular immunology.
[112] S. Gendler,et al. Regulation of mucin genes in chronic inflammatory airway diseases. , 2006, American journal of respiratory cell and molecular biology.
[113] S. Gendler,et al. Transgenic MUC1 Interacts with Epidermal Growth Factor Receptor and Correlates with Mitogen-activated Protein Kinase Activation in the Mouse Mammary Gland* , 2001, The Journal of Biological Chemistry.
[114] J. Rhodes,et al. Circulating galectin-3 promotes metastasis by modifying MUC1 localization on cancer cell surface. , 2009, Cancer research.
[115] T. Irimura,et al. Tumor-associated Tn-MUC1 glycoform is internalized through the macrophage galactose-type C-type lectin and delivered to the HLA class I and II compartments in dendritic cells. , 2007, Cancer research.
[116] D. Zander,et al. MUC4 expression in non-small cell lung carcinomas: relationship to tumor histology and patient survival. , 2007, Archives of pathology & laboratory medicine.
[117] H. Friess,et al. Mucin (MUC) gene expression in human pancreatic adenocarcinoma and chronic pancreatitis: a potential role of MUC4 as a tumor marker of diagnostic significance. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[118] M. Hollingsworth,et al. Expression of core 3 synthase in human pancreatic cancer cells suppresses tumor growth and metastasis , 2013, International journal of cancer.
[119] S. Kawa,et al. Clinical evaluation of pancreatic cancer-associated mucin expressing CA19-9, CA50, Span-1, sialyl SSEA-1, and Dupan-2. , 1992, Scandinavian journal of gastroenterology.
[120] M. Hollingsworth,et al. Interactions between MUC1 and p120 catenin regulate dynamic features of cell adhesion, motility, and metastasis. , 2014, Cancer research.
[121] Hongyan Yuan,et al. Mucin1 promotes the migration and invasion of hepatocellular carcinoma cells via JNK-mediated phosphorylation of Smad2 at the C-terminal and linker regions , 2015, Oncotarget.
[122] J. Taylor‐Papadimitriou,et al. The Breast Cancer-Associated Glycoforms of MUC1, MUC1-Tn and sialyl-Tn, Are Expressed in COSMC Wild-Type Cells and Bind the C-Type Lectin MGL , 2015, PloS one.
[123] Jane L Meza,et al. MUC4 Mucin Potentiates Pancreatic Tumor Cell Proliferation, Survival, and Invasive Properties and Interferes with Its Interaction to Extracellular Matrix Proteins , 2007, Molecular Cancer Research.
[124] D. Kufe,et al. The c-Src Tyrosine Kinase Regulates Signaling of the Human DF3/MUC1 Carcinoma-associated Antigen with GSK3β and β-Catenin* , 2001, The Journal of Biological Chemistry.
[125] Masanobu Komatsu,et al. Muc4/sialomucin complex, an intramembrane modulator of ErbB2/HER2/Neu, potentiates primary tumor growth and suppresses apoptosis in a xenotransplanted tumor , 2001, Oncogene.
[126] P. Schwartz,et al. Circulating tumor markers in the monitoring of gynecologic malignancies , 1987, Cancer.
[127] G. Rutteman,et al. Sialylation regulates galectin-3/ligand interplay during mammary tumour progression--a case of targeted uncloaking. , 2011, The International journal of developmental biology.
[128] Jing-Jing Zhang,et al. MUC4-induced nuclear translocation of β-catenin: a novel mechanism for growth, metastasis and angiogenesis in pancreatic cancer. , 2014, Cancer letters.
[129] J. D. Capra,et al. High-level production of a functional immunoglobulin heterodimer in a baculovirus expression system. , 1990, Proceedings of the National Academy of Sciences of the United States of America.
[130] P. De Camilli,et al. CIN85 associates with multiple effectors controlling intracellular trafficking of epidermal growth factor receptors. , 2004, Molecular biology of the cell.
[131] L. Coupland,et al. Platelets, selectins, and the control of tumor metastasis. , 2014, Seminars in oncology.
[132] S. Batra,et al. MUC4 stabilizes HER2 expression and maintains the cancer stem cell population in ovarian cancer cells , 2011, Journal of ovarian research.
[133] Timothy J. Yeatman,et al. A renaissance for SRC , 2004, Nature Reviews Cancer.
[134] Ping Li,et al. Loss of Core 1-derived O-Glycans Decreases Breast Cancer Development in Mice* , 2015, The Journal of Biological Chemistry.
[135] H. Nakanishi,et al. Molecular Cloning and Characterization of a Novel UDP-GlcNAc:GalNAc-peptide β1,3-N-Acetylglucosaminyltransferase (β3Gn-T6), an Enzyme Synthesizing the Core 3 Structure of O-Glycans* , 2002, The Journal of Biological Chemistry.
[136] Lynette M. Smith,et al. Carboxyl-terminal domain of MUC16 imparts tumorigenic and metastatic functions through nuclear translocation of JAK2 to pancreatic cancer cells , 2015, Oncotarget.
[137] M. Fukuda,et al. Expression cloning of a cDNA encoding UDP-GlcNAc:Gal beta 1-3-GalNAc-R (GlcNAc to GalNAc) beta 1-6GlcNAc transferase by gene transfer into CHO cells expressing polyoma large tumor antigen. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[138] S. Batra,et al. Role of MUC4-NIDO domain in the MUC4-mediated metastasis of pancreatic cancer cells , 2011, Oncogene.
[139] Judy M. Anderson,et al. Aberrant Expression of Mucin Core Proteins and O-Linked Glycans Associated with Progression of Pancreatic Cancer , 2013, Clinical Cancer Research.
[140] P. Singh,et al. Phosphorylation of MUC1 by Met Modulates Interaction with p53 and MMP1 Expression* , 2008, Journal of Biological Chemistry.
[141] R. Cummings,et al. Epigenetic Silencing of the Chaperone Cosmc in Human Leukocytes Expressing Tn Antigen , 2022 .
[142] G. Huet,et al. Galectin-3 regulates MUC1 and EGFR cellular distribution and EGFR downstream pathways in pancreatic cancer cells , 2011, Oncogene.
[143] S. Batra,et al. A role for human MUC4 mucin gene, the ErbB2 ligand, as a target of TGF-β in pancreatic carcinogenesis , 2004, Oncogene.
[144] B. Xia,et al. Human tumor antigens Tn and sialyl Tn arise from mutations in Cosmc. , 2008, Cancer research.
[145] Matthew R. Dallas,et al. Mucin 16 is a functional selectin ligand on pancreatic cancer cells , 2012, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[146] R. Hill,et al. Porcine submaxillary gland apomucin contains tandemly repeated, identical sequences of 81 residues. , 1988, The Journal of biological chemistry.
[147] N. Smorodinsky,et al. The MUC1 SEA Module Is a Self-cleaving Domain* , 2005, Journal of Biological Chemistry.
[148] D. Meerzaman,et al. Involvement of the MAP kinase ERK2 in MUC1 mucin signaling. , 2001, American journal of physiology. Lung cellular and molecular physiology.
[149] Sangeeta Bafna,et al. Aberrant expression of transmembrane mucins, MUC1 and MUC4, in human prostate carcinomas , 2006, The Prostate.
[150] M. Pasumarthy,et al. Site-specific Core 1 O-Glycosylation Pattern of the Porcine Submaxillary Gland Mucin Tandem Repeat , 1998, The Journal of Biological Chemistry.
[151] B. Pockaj,et al. Aberrant Glycosylation of Anchor-Optimized MUC1 Peptides Can Enhance Antigen Binding Affinity and Reverse Tolerance to Cytotoxic T Lymphocytes , 2016, Biomolecules.
[152] M. McGuckin,et al. Structure and function of the polymeric mucins in airways mucus. , 2008, Annual review of physiology.
[153] J. Jiménez-Barbero,et al. Thermodynamic Switch in Binding of Adhesion/Growth Regulatory Human Galectin-3 to Tumor-Associated TF Antigen (CD176) and MUC1 Glycopeptides , 2015, Biochemistry.
[154] H. Wandall,et al. Glycan Elongation Beyond the Mucin Associated Tn Antigen Protects Tumor Cells from Immune-Mediated Killing , 2013, PloS one.
[155] Benjamin G. Bitler,et al. MUC1 regulates nuclear localization and function of the epidermal growth factor receptor , 2010, Journal of Cell Science.
[156] S. Batra,et al. MUC4 activates HER2 signalling and enhances the motility of human ovarian cancer cells , 2008, British Journal of Cancer.
[157] Ronald J Moore,et al. Ischemia in Tumors Induces Early and Sustained Phosphorylation Changes in Stress Kinase Pathways but Does Not Affect Global Protein Levels* , 2014, Molecular & Cellular Proteomics.
[158] S. Batra,et al. Mucin Expression in Endoscopic Ultrasound-Guided Fine-Needle Aspiration Specimens Is a Useful Prognostic Factor in Pancreatic Ductal Adenocarcinoma , 2015, Pancreas.